Jimmy Fund Press Releases
2018
New gene therapy strategy for sickle cell disease shows early promise in humans
December 01, 2018A 21-year-old patient with severe sickle cell disease is symptom-free after gene therapy knocks down BCL11A, restoring fetal hemoglobin production.
Pan-Mass Challenge Announces Unprecedented $56 Million Gift to Dana-Farber Cancer Institute
November 04, 2018The Pan-Mass Challenge announced an unprecedented $56 million gift to Dana-Farber. The organization exceeded its fundraising goal, bringing its 39-year total to $654 million.
Dana-Farber/Brigham and Women's Cancer Center recognized as the best in the region, and among the nation’s best, for 18th consecutive year
August 14, 2018Dana-Farber/Brigham and Women's Cancer Center recognized as the best in the region, and among the nation’s best, for 18th consecutive year
Dana-Farber/Boston Children's again ranked among the top national pediatric cancer programs
June 26, 2018U.S. News & World Report has ranked Dana-Farber/Boston Children's Cancer and Blood Disorders Center the top pediatric cancer program in New England and #3 in the nation.
Dana-Farber/Brigham and Women’s Cancer Center offers CAR T-cell therapy Kymriah™, now approved for lymphoma
May 01, 2018Dana-Farber is a certified treatment center for the just approved CAR T-cell therapy, tisagenlecleucel (Kymriah™) for certain lymphoma patients.
Patients and researchers team up to fight metastatic prostate cancer
February 26, 2018Researchers launched the Metastatic Prostate Cancer Project (MPC), a patient-partnered initiative that encourages men with metastatic prostate cancer across the U.S. and Canada to collaborate.